APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metoclopramide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metoclopramide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025195 pages

Choose your research edition.

Industry ResearchMetoclopramide Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Metoclopramide Industry Growth and Trends Forecast to 2032129 pages · $3,450 USDMarket StructureGlobal Metoclopramide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032195 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metoclopramide Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Metoclopramide Market Analysis and Forecast 2026-2032214 pages · $4,950 USD

Market perspective

The global Metoclopramide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Metoclopramide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metoclopramide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metoclopramide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metoclopramide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metoclopramide include Adwya, Alkaloid Pharmaceuticals, Amneal Pharmaceuticals, Apotex, ASKA Seiyaku Asuka, Astellas, Biofarma, Ceva Sante Animale and EU-Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metoclopramide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metoclopramide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metoclopramide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metoclopramide market size, projected growth trends, production technologies, key applications, and end-use industries.

Metoclopramide Segment by Company

Adwya

Alkaloid Pharmaceuticals

Amneal Pharmaceuticals

Apotex

ASKA Seiyaku Asuka

Astellas

Biofarma

Ceva Sante Animale

EU-Pharma

Le Vet

Meda Pharma

Nidda

Omega Laboratories

Orion Pharma

Teuto Brasileiro

Wockhardt

Yang Sheng

GSK

Pfizer

Mylan

Novartis

Johnson and Johnson

Sanofi

Teva

Metoclopramide Segment by Type

Oral

Injection

Metoclopramide Segment by Application

Nausea

Migraine

Gastroparesis

Metoclopramide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metoclopramide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metoclopramide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metoclopramide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metoclopramide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metoclopramide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Metoclopramide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Metoclopramide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Metoclopramide Industry Trends Table 2. Metoclopramide Industry Drivers Table 3. Metoclopramide Industry Opportunities and Challenges Table 4. Metoclopramide Industry Restraints Table 5. Global Metoclopramide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Metoclopramide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Metoclopramide Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Metoclopramide Sales Market Share by Manufacturers Table 9. Global Metoclopramide Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Metoclopramide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Metoclopramide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Metoclopramide Manufacturers, Product Type & Application Table 13. Global Metoclopramide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Metoclopramide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Oral Table 17. Major Manufacturers of Injection Table 18. Global Metoclopramide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Metoclopramide Sales by Type (2021-2026) & (K Units) Table 20. Global Metoclopramide Sales by Type (2027-2032) & (K Units) Table 21. Global Metoclopramide Sales Market Share by Type (2021-2026) Table 22. Global Metoclopramide Sales Market Share by Type (2027-2032) Table 23. Global Metoclopramide Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Metoclopramide Revenue by Type (2021-2026) & (K Units) Table 25. Global Metoclopramide Revenue by Type (2027-2032) & (K Units) Table 26. Global Metoclopramide Revenue Market Share by Type (2021-2026) Table 27. Global Metoclopramide Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Nausea Table 29. Major Manufacturers of Migraine Table 30. Major Manufacturers of Gastroparesis Table 31. Global Metoclopramide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Metoclopramide Sales by Application (2021-2026) & (K Units) Table 33. Global Metoclopramide Sales by Application (2027-2032) & (K Units) Table 34. Global Metoclopramide Sales Market Share by Application (2021-2026) Table 35. Global Metoclopramide Sales Market Share by Application (2027-2032) Table 36. Global Metoclopramide Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Metoclopramide Revenue by Application (2021-2026) & (K Units) Table 38. Global Metoclopramide Revenue by Application (2027-2032) & (K Units) Table 39. Global Metoclopramide Revenue Market Share by Application (2021-2026) Table 40. Global Metoclopramide Revenue Market Share by Application (2027-2032) Table 41. Global Metoclopramide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Metoclopramide Sales by Region (2021-2026) & (K Units) Table 43. Global Metoclopramide Sales Market Share by Region (2021-2026) Table 44. Global Metoclopramide Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Metoclopramide Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Metoclopramide Sales by Country (2021-2026) & (K Units) Table 48. North America Metoclopramide Sales by Country (2027-2032) & (K Units) Table 49. Europe Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Metoclopramide Sales by Country (2021-2026) & (K Units) Table 51. Europe Metoclopramide Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Metoclopramide Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Metoclopramide Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Metoclopramide Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Metoclopramide Sales by Country (2027-2032) & (K Units) Table 58. Global Metoclopramide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Metoclopramide Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Metoclopramide Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Metoclopramide Revenue Market Share by Region (2021-2026) Table 62. Global Metoclopramide Revenue Market Share by Region (2027-2032) Table 63. Adwya Company Information Table 64. Adwya Business Overview Table 65. Adwya Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Adwya Metoclopramide Product Portfolio Table 67. Adwya Recent Development Table 68. Alkaloid Pharmaceuticals Company Information Table 69. Alkaloid Pharmaceuticals Business Overview Table 70. Alkaloid Pharmaceuticals Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Alkaloid Pharmaceuticals Metoclopramide Product Portfolio Table 72. Alkaloid Pharmaceuticals Recent Development Table 73. Amneal Pharmaceuticals Company Information Table 74. Amneal Pharmaceuticals Business Overview Table 75. Amneal Pharmaceuticals Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Amneal Pharmaceuticals Metoclopramide Product Portfolio Table 77. Amneal Pharmaceuticals Recent Development Table 78. Apotex Company Information Table 79. Apotex Business Overview Table 80. Apotex Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Apotex Metoclopramide Product Portfolio Table 82. Apotex Recent Development Table 83. ASKA Seiyaku Asuka Company Information Table 84. ASKA Seiyaku Asuka Business Overview Table 85. ASKA Seiyaku Asuka Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. ASKA Seiyaku Asuka Metoclopramide Product Portfolio Table 87. ASKA Seiyaku Asuka Recent Development Table 88. Astellas Company Information Table 89. Astellas Business Overview Table 90. Astellas Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Astellas Metoclopramide Product Portfolio Table 92. Astellas Recent Development Table 93. Biofarma Company Information Table 94. Biofarma Business Overview Table 95. Biofarma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Biofarma Metoclopramide Product Portfolio Table 97. Biofarma Recent Development Table 98. Ceva Sante Animale Company Information Table 99. Ceva Sante Animale Business Overview Table 100. Ceva Sante Animale Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Ceva Sante Animale Metoclopramide Product Portfolio Table 102. Ceva Sante Animale Recent Development Table 103. EU-Pharma Company Information Table 104. EU-Pharma Business Overview Table 105. EU-Pharma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. EU-Pharma Metoclopramide Product Portfolio Table 107. EU-Pharma Recent Development Table 108. Le Vet Company Information Table 109. Le Vet Business Overview Table 110. Le Vet Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Le Vet Metoclopramide Product Portfolio Table 112. Le Vet Recent Development Table 113. Meda Pharma Company Information Table 114. Meda Pharma Business Overview Table 115. Meda Pharma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Meda Pharma Metoclopramide Product Portfolio Table 117. Meda Pharma Recent Development Table 118. Nidda Company Information Table 119. Nidda Business Overview Table 120. Nidda Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Nidda Metoclopramide Product Portfolio Table 122. Nidda Recent Development Table 123. Omega Laboratories Company Information Table 124. Omega Laboratories Business Overview Table 125. Omega Laboratories Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Omega Laboratories Metoclopramide Product Portfolio Table 127. Omega Laboratories Recent Development Table 128. Orion Pharma Company Information Table 129. Orion Pharma Business Overview Table 130. Orion Pharma Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Orion Pharma Metoclopramide Product Portfolio Table 132. Orion Pharma Recent Development Table 133. Teuto Brasileiro Company Information Table 134. Teuto Brasileiro Business Overview Table 135. Teuto Brasileiro Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Teuto Brasileiro Metoclopramide Product Portfolio Table 137. Teuto Brasileiro Recent Development Table 138. Wockhardt Company Information Table 139. Wockhardt Business Overview Table 140. Wockhardt Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Wockhardt Metoclopramide Product Portfolio Table 142. Wockhardt Recent Development Table 143. Yang Sheng Company Information Table 144. Yang Sheng Business Overview Table 145. Yang Sheng Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Yang Sheng Metoclopramide Product Portfolio Table 147. Yang Sheng Recent Development Table 148. GSK Company Information Table 149. GSK Business Overview Table 150. GSK Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. GSK Metoclopramide Product Portfolio Table 152. GSK Recent Development Table 153. Pfizer Company Information Table 154. Pfizer Business Overview Table 155. Pfizer Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 156. Pfizer Metoclopramide Product Portfolio Table 157. Pfizer Recent Development Table 158. Mylan Company Information Table 159. Mylan Business Overview Table 160. Mylan Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 161. Mylan Metoclopramide Product Portfolio Table 162. Mylan Recent Development Table 163. Novartis Company Information Table 164. Novartis Business Overview Table 165. Novartis Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 166. Novartis Metoclopramide Product Portfolio Table 167. Novartis Recent Development Table 168. Johnson and Johnson Company Information Table 169. Johnson and Johnson Business Overview Table 170. Johnson and Johnson Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 171. Johnson and Johnson Metoclopramide Product Portfolio Table 172. Johnson and Johnson Recent Development Table 173. Sanofi Company Information Table 174. Sanofi Business Overview Table 175. Sanofi Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 176. Sanofi Metoclopramide Product Portfolio Table 177. Sanofi Recent Development Table 178. Teva Company Information Table 179. Teva Business Overview Table 180. Teva Metoclopramide Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 181. Teva Metoclopramide Product Portfolio Table 182. Teva Recent Development Table 183. Key Raw Materials Table 184. Raw Materials Key Suppliers Table 185. Metoclopramide Distributors List Table 186. Metoclopramide Customers List Table 187. Research Programs/Design for This Report Table 188. Authors List of This Report Table 189. Secondary Sources Table 190. Primary Sources List of Figures Figure 1. Metoclopramide Product Image Figure 2. Global Metoclopramide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metoclopramide Market Size (2021-2032) & (US$ Million) Figure 4. Global Metoclopramide Sales (2021-2032) & (K Units) Figure 5. Global Metoclopramide Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Metoclopramide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Oral Image Figure 9. Injection Image Figure 10. Global Metoclopramide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Metoclopramide Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Metoclopramide Sales Market Share by Type (2021-2032) Figure 13. Global Metoclopramide Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Metoclopramide Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Metoclopramide Revenue Market Share by Type (2021-2032) Figure 16. Nausea Image Figure 17. Migraine Image Figure 18. Gastroparesis Image Figure 19. Global Metoclopramide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Metoclopramide Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Metoclopramide Sales Market Share by Application (2021-2032) Figure 22. Global Metoclopramide Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Metoclopramide Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Metoclopramide Revenue Market Share by Application (2021-2032) Figure 25. North America Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Metoclopramide Sales Market Share by Country (2021-2032) Figure 27. U.S. Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Metoclopramide Sales Market Share by Country (2021-2032) Figure 32. Germany Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Metoclopramide Sales Market Share by Country (2021-2032) Figure 39. China Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Metoclopramide Sales Market Share by Country (2021-2032) Figure 47. Brazil Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Metoclopramide Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Metoclopramide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Metoclopramide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Metoclopramide Revenue (2021-2032) & (US$ Million) Figure 58. North America Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Metoclopramide Revenue (2021-2032) & (US$ Million) Figure 60. Europe Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Metoclopramide Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Metoclopramide Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Metoclopramide Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Metoclopramide Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Nausea
  • Migraine
  • Gastroparesis
Companies covered
  • Adwya
  • Alkaloid Pharmaceuticals
  • Amneal Pharmaceuticals
  • Apotex
  • ASKA Seiyaku Asuka
  • Astellas
  • Biofarma
  • Ceva Sante Animale
  • EU-Pharma
  • Le Vet
  • Meda Pharma
  • Nidda
  • Omega Laboratories
  • Orion Pharma
  • Teuto Brasileiro
  • Wockhardt
  • Yang Sheng
  • GSK
  • Pfizer
  • Mylan
  • Novartis
  • Johnson and Johnson
  • Sanofi
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metoclopramide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metoclopramide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Metoclopramide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Metoclopramide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Metoclopramide Market Dynamics
  1. 2.1 Metoclopramide Industry Trends
  2. 2.2 Metoclopramide Industry Drivers
  3. 2.3 Metoclopramide Industry Opportunities and Challenges
  4. 2.4 Metoclopramide Industry Restraints
3 Metoclopramide Market by Manufacturers
  1. 3.1 Global Metoclopramide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Metoclopramide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Metoclopramide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Metoclopramide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metoclopramide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Metoclopramide Manufacturers, Product Type & Application
  7. 3.7 Global Metoclopramide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metoclopramide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metoclopramide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metoclopramide Tier 1, Tier 2, and Tier 3
4 Metoclopramide Market by Type
  1. 4.1 Metoclopramide Type Introduction
  2. 4.1.1 Oral
  3. 4.1.2 Injection
  4. 4.2 Global Metoclopramide Sales by Type
  5. 4.2.1 Global Metoclopramide Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Metoclopramide Sales by Type (2021-2032)
  7. 4.2.3 Global Metoclopramide Sales Market Share by Type (2021-2032)
  8. 4.3 Global Metoclopramide Revenue by Type
  9. 4.3.1 Global Metoclopramide Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Metoclopramide Revenue by Type (2021-2032)
  11. 4.3.3 Global Metoclopramide Revenue Market Share by Type (2021-2032)
5 Metoclopramide Market by Application
  1. 5.1 Metoclopramide Application Introduction
  2. 5.1.1 Nausea
  3. 5.1.2 Migraine
  4. 5.1.3 Gastroparesis
  5. 5.2 Global Metoclopramide Sales by Application
  6. 5.2.1 Global Metoclopramide Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Metoclopramide Sales by Application (2021-2032)
  8. 5.2.3 Global Metoclopramide Sales Market Share by Application (2021-2032)
  9. 5.3 Global Metoclopramide Revenue by Application
  10. 5.3.1 Global Metoclopramide Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Metoclopramide Revenue by Application (2021-2032)
  12. 5.3.3 Global Metoclopramide Revenue Market Share by Application (2021-2032)
6 Global Metoclopramide Sales by Region
  1. 6.1 Global Metoclopramide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metoclopramide Sales by Region (2021-2032)
  3. 6.2.1 Global Metoclopramide Sales by Region (2021-2026)
  4. 6.2.2 Global Metoclopramide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Metoclopramide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Metoclopramide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Metoclopramide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Metoclopramide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Metoclopramide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Metoclopramide Revenue by Region
  1. 7.1 Global Metoclopramide Revenue by Region
  2. 7.1.1 Global Metoclopramide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Metoclopramide Revenue by Region (2021-2026)
  4. 7.1.3 Global Metoclopramide Revenue by Region (2027-2032)
  5. 7.1.4 Global Metoclopramide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Metoclopramide Revenue (2021-2032)
  8. 7.2.2 North America Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Metoclopramide Revenue (2021-2032)
  11. 7.3.2 Europe Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Metoclopramide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Metoclopramide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Metoclopramide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Adwya
  2. 8.1.1 Adwya Company Information
  3. 8.1.2 Adwya Business Overview
  4. 8.1.3 Adwya Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Adwya Metoclopramide Product Portfolio
  6. 8.1.5 Adwya Recent Developments
  7. 8.2 Alkaloid Pharmaceuticals
  8. 8.2.1 Alkaloid Pharmaceuticals Company Information
  9. 8.2.2 Alkaloid Pharmaceuticals Business Overview
  10. 8.2.3 Alkaloid Pharmaceuticals Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Alkaloid Pharmaceuticals Metoclopramide Product Portfolio
  12. 8.2.5 Alkaloid Pharmaceuticals Recent Developments
  13. 8.3 Amneal Pharmaceuticals
  14. 8.3.1 Amneal Pharmaceuticals Company Information
  15. 8.3.2 Amneal Pharmaceuticals Business Overview
  16. 8.3.3 Amneal Pharmaceuticals Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Amneal Pharmaceuticals Metoclopramide Product Portfolio
  18. 8.3.5 Amneal Pharmaceuticals Recent Developments
  19. 8.4 Apotex
  20. 8.4.1 Apotex Company Information
  21. 8.4.2 Apotex Business Overview
  22. 8.4.3 Apotex Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Apotex Metoclopramide Product Portfolio
  24. 8.4.5 Apotex Recent Developments
  25. 8.5 ASKA Seiyaku Asuka
  26. 8.5.1 ASKA Seiyaku Asuka Company Information
  27. 8.5.2 ASKA Seiyaku Asuka Business Overview
  28. 8.5.3 ASKA Seiyaku Asuka Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 ASKA Seiyaku Asuka Metoclopramide Product Portfolio
  30. 8.5.5 ASKA Seiyaku Asuka Recent Developments
  31. 8.6 Astellas
  32. 8.6.1 Astellas Company Information
  33. 8.6.2 Astellas Business Overview
  34. 8.6.3 Astellas Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Astellas Metoclopramide Product Portfolio
  36. 8.6.5 Astellas Recent Developments
  37. 8.7 Biofarma
  38. 8.7.1 Biofarma Company Information
  39. 8.7.2 Biofarma Business Overview
  40. 8.7.3 Biofarma Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Biofarma Metoclopramide Product Portfolio
  42. 8.7.5 Biofarma Recent Developments
  43. 8.8 Ceva Sante Animale
  44. 8.8.1 Ceva Sante Animale Company Information
  45. 8.8.2 Ceva Sante Animale Business Overview
  46. 8.8.3 Ceva Sante Animale Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Ceva Sante Animale Metoclopramide Product Portfolio
  48. 8.8.5 Ceva Sante Animale Recent Developments
  49. 8.9 EU-Pharma
  50. 8.9.1 EU-Pharma Company Information
  51. 8.9.2 EU-Pharma Business Overview
  52. 8.9.3 EU-Pharma Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 EU-Pharma Metoclopramide Product Portfolio
  54. 8.9.5 EU-Pharma Recent Developments
  55. 8.10 Le Vet
  56. 8.10.1 Le Vet Company Information
  57. 8.10.2 Le Vet Business Overview
  58. 8.10.3 Le Vet Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Le Vet Metoclopramide Product Portfolio
  60. 8.10.5 Le Vet Recent Developments
  61. 8.11 Meda Pharma
  62. 8.11.1 Meda Pharma Company Information
  63. 8.11.2 Meda Pharma Business Overview
  64. 8.11.3 Meda Pharma Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Meda Pharma Metoclopramide Product Portfolio
  66. 8.11.5 Meda Pharma Recent Developments
  67. 8.12 Nidda
  68. 8.12.1 Nidda Company Information
  69. 8.12.2 Nidda Business Overview
  70. 8.12.3 Nidda Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Nidda Metoclopramide Product Portfolio
  72. 8.12.5 Nidda Recent Developments
  73. 8.13 Omega Laboratories
  74. 8.13.1 Omega Laboratories Company Information
  75. 8.13.2 Omega Laboratories Business Overview
  76. 8.13.3 Omega Laboratories Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Omega Laboratories Metoclopramide Product Portfolio
  78. 8.13.5 Omega Laboratories Recent Developments
  79. 8.14 Orion Pharma
  80. 8.14.1 Orion Pharma Company Information
  81. 8.14.2 Orion Pharma Business Overview
  82. 8.14.3 Orion Pharma Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Orion Pharma Metoclopramide Product Portfolio
  84. 8.14.5 Orion Pharma Recent Developments
  85. 8.15 Teuto Brasileiro
  86. 8.15.1 Teuto Brasileiro Company Information
  87. 8.15.2 Teuto Brasileiro Business Overview
  88. 8.15.3 Teuto Brasileiro Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Teuto Brasileiro Metoclopramide Product Portfolio
  90. 8.15.5 Teuto Brasileiro Recent Developments
  91. 8.16 Wockhardt
  92. 8.16.1 Wockhardt Company Information
  93. 8.16.2 Wockhardt Business Overview
  94. 8.16.3 Wockhardt Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Wockhardt Metoclopramide Product Portfolio
  96. 8.16.5 Wockhardt Recent Developments
  97. 8.17 Yang Sheng
  98. 8.17.1 Yang Sheng Company Information
  99. 8.17.2 Yang Sheng Business Overview
  100. 8.17.3 Yang Sheng Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Yang Sheng Metoclopramide Product Portfolio
  102. 8.17.5 Yang Sheng Recent Developments
  103. 8.18 GSK
  104. 8.18.1 GSK Company Information
  105. 8.18.2 GSK Business Overview
  106. 8.18.3 GSK Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 GSK Metoclopramide Product Portfolio
  108. 8.18.5 GSK Recent Developments
  109. 8.19 Pfizer
  110. 8.19.1 Pfizer Company Information
  111. 8.19.2 Pfizer Business Overview
  112. 8.19.3 Pfizer Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Pfizer Metoclopramide Product Portfolio
  114. 8.19.5 Pfizer Recent Developments
  115. 8.20 Mylan
  116. 8.20.1 Mylan Company Information
  117. 8.20.2 Mylan Business Overview
  118. 8.20.3 Mylan Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Mylan Metoclopramide Product Portfolio
  120. 8.20.5 Mylan Recent Developments
  121. 8.21 Novartis
  122. 8.21.1 Novartis Company Information
  123. 8.21.2 Novartis Business Overview
  124. 8.21.3 Novartis Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Novartis Metoclopramide Product Portfolio
  126. 8.21.5 Novartis Recent Developments
  127. 8.22 Johnson and Johnson
  128. 8.22.1 Johnson and Johnson Company Information
  129. 8.22.2 Johnson and Johnson Business Overview
  130. 8.22.3 Johnson and Johnson Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Johnson and Johnson Metoclopramide Product Portfolio
  132. 8.22.5 Johnson and Johnson Recent Developments
  133. 8.23 Sanofi
  134. 8.23.1 Sanofi Company Information
  135. 8.23.2 Sanofi Business Overview
  136. 8.23.3 Sanofi Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Sanofi Metoclopramide Product Portfolio
  138. 8.23.5 Sanofi Recent Developments
  139. 8.24 Teva
  140. 8.24.1 Teva Company Information
  141. 8.24.2 Teva Business Overview
  142. 8.24.3 Teva Metoclopramide Sales, Price, Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Teva Metoclopramide Product Portfolio
  144. 8.24.5 Teva Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metoclopramide Value Chain Analysis
  2. 9.1.1 Metoclopramide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metoclopramide Production Mode & Process
  6. 9.2 Metoclopramide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metoclopramide Distributors
  9. 9.2.3 Metoclopramide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst